Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversitätsklinikum Hamburg-Eppendorf

About this trial

Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by different motor symptoms, including tremor, which is particularly difficult to manage. Common treatments, such as dopaminergic therapy, can have limitations in efficacy. Recent advancements in non-invasive brain stimulation, specifically phase-adaptive transcranial alternating current stimulation (tACS), offer a promising approach to reduce PD tremor. In the current project, a newly developed closed-loop system delivers precisely synchronized cerebellar tACS by aligning stimulation with the intrinsic hand tremor signal. The study will assess the efficacy of this novel approach to reduce hand tremor in PD patients.

Eligibility criteria

Qualifiers

Clinical diagnosis of Parkinson's disease based on UK Brain Bank criteria

Patient exhibiting moderate to severe hand tremor

Provision written informed consent by the patient

Disqualifiers

History of other neurological disorders such as vascular malformations, ischemic or haemorrhagic stroke, cerebral neoplasia, epilepsy, or major psychiatric illness

Existence of heart pacemaker or metal implants in the body

Pregnancy

Trial design

Treatments tested in this trial

  • Active-tACS
  • Sham-tACS
  • Unlocked-tACS

Treatment groups

10 Participants
are divided into 3 treatment groups